Both in Biotechnology
Beam Therapeutics vs Iovance Biotherapeutics
Over the past year BEAM returned +8.6% and IOVA returned +352.8%; their daily moves had a correlation of 0.30.
BEAM +8.6% IOVA +352.8%Growth of $1, one year, split-adjusted
| Metric | BEAM | IOVA |
|---|---|---|
| Price | $26.33 | $8.83 |
| Market cap | $2.72B | $4.00B |
| Today | +1.78% | +10.10% |
| 1 month | +2.6% | −37.6% |
| 6 months | −8.9% | +121.9% |
| Year to date | −5.0% | +223.4% |
| 1 year | +5.3% | +348.2% |
| Revenue growth (YoY) | −94.2% | +65.7% |
| Gross margin | 100.0% | 56.1% |
| Net margin | −25036.3% | −47.6% |
| P/E (TTM) | — | — |
| Price / sales | 17.4× | 12.3× |
| Net cash | $1.05B | $297.7M |
| Dividend yield | — | — |
| Volatility (60d) | 63.4% | 130.2% |
| Short % of float | 32.0% | 15.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).